Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PUT
Stryker
SYK
$130B
| $8.72M | 0.01% |
56,300
+12,900
| +30% | +$1.97M |
|
1752
Acushnet Holdings
GOLF
$5.26B
| $8.71M | 0.01% |
412,982
-863,703
| -68% | -$16.4M |
|
1753
Ventas
VTR
$46.9B
| $8.7M | 0.01% |
144,995
+127,790
| +743% | +$8.08M |
|
|
BBBY
1754
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
| $8.7M | 0.01% |
395,700
+178,800
| +82% | +$3.88M |
|
1755
PUT
Ciena
CIEN
$60.7B
| $8.67M | 0.01% |
414,300
+204,700
| +98% | +$4.34M |
|
1756
STMicroelectronics
STM
$48.5B
| $8.67M | 0.01% |
397,018
-1,244,819
| -76% | -$27.6M |
|
1757
PUT
Ferrari
RACE
$72.9B
| $8.67M | 0.01% |
82,700
-22,200
| -21% | -$2.47M |
|
1758
CALL
Applied Optoelectronics
AAOI
$12.7B
| $8.66M | 0.01% |
229,100
-117,900
| -34% | -$5.2M |
|
1759
Dolby
DLB
$5.84B
| $8.65M | 0.01% |
139,462
+123,683
| +784% | +$7.47M |
|
1760
Charles River Laboratories
CRL
$13.4B
| $8.65M | 0.01% |
78,995
+45,952
| +139% | +$5M |
|
1761
CALL
Royal Caribbean
RCL
$81.6B
| $8.64M | 0.01% |
72,400
-64,900
| -47% | -$8.03M |
|
1762
PUT
Sarepta Therapeutics
SRPT
$1.91B
| $8.63M | 0.01% |
155,200
-55,300
| -26% | -$2.93M |
|
|
CLVS
1763
DELISTED
Clovis Oncology, Inc.
CLVS
| $8.62M | 0.01% |
126,803
-1,228,025
| -91% | -$85.9M |
|
1764
Encompass Health
EHC
$12.2B
| $8.61M | 0.01% |
219,017
-90,730
| -29% | -$3.45M |
|
|
MOMO
1765
PUT
Hello Group
MOMO
$850M
| $8.61M | 0.01% |
351,500
+149,300
| +74% | +$4.3M |
|
1766
CALL
United Parks & Resorts
PRKS
$2.04B
| $8.6M | 0.01% |
633,900
+447,400
| +240% | +$5.57M |
|
1767
PUT
Wolfspeed
WOLF
$1.65B
| $8.59M | 0.01% |
231,300
+124,400
| +116% | +$4.29M |
|
|
VRNT
1768
DELISTED
Verint Systems
VRNT
| $8.57M | 0.01% |
402,227
-701,692
| -64% | -$15.1M |
|
|
RDS.B
1769
PUT
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $8.57M | 0.01% |
125,500
+81,500
| +185% | +$5.28M |
|
1770
Trimble
TRMB
$13.4B
| $8.56M | 0.01% |
210,531
+199,895
| +1,879% | +$8.19M |
|
1771
Amplify Cybersecurity ETF
HACK
$2.98B
| $8.54M | 0.01% |
269,850
+130,603
| +94% | +$4.03M |
|
1772
NewMarket
NEU
$8.85B
| $8.53M | 0.01% |
21,461
+6,716
| +46% | +$2.72M |
|
1773
Paychex
PAYX
$43.4B
| $8.53M | 0.01% |
125,264
-1,163,069
| -90% | -$76.3M |
|
1774
Kennametal
KMT
$2.38B
| $8.52M | 0.01% |
+176,018
| New | +$7.84M |
|
|
IRDMB
1775
DELISTED
Iridium Communications Inc - 6.75% Series B
IRDMB
| $8.52M | 0.01% |
20,700
+3,750
| +22% | +$1.52M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.